Royal Bank of Canada’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Buy |
9,563
+8,264
| +636% | +$112K | ﹤0.01% | 5118 |
|
|
2025
Q1 | $21K | Sell |
1,299
-2,236
| -63% | -$36.1K | ﹤0.01% | 5526 |
|
|
2024
Q4 | $43K | Buy |
3,535
+661
| +23% | +$8.04K | ﹤0.01% | 5275 |
|
|
2024
Q3 | $34K | Buy |
2,874
+179
| +7% | +$2.12K | ﹤0.01% | 5404 |
|
|
2024
Q2 | $31K | Buy |
2,695
+2,251
| +507% | +$25.9K | ﹤0.01% | 5482 |
|
|
2024
Q1 | $6K | Sell |
444
-5,961
| -93% | -$80.6K | ﹤0.01% | 5938 |
|
|
2023
Q4 | $55K | Buy |
6,405
+4,213
| +192% | +$36.2K | ﹤0.01% | 5406 |
|
|
2023
Q3 | $21K | Buy |
2,192
+887
| +68% | +$8.5K | ﹤0.01% | 5671 |
|
|
2023
Q2 | $22K | Buy |
1,305
+411
| +46% | +$6.93K | ﹤0.01% | 5710 |
|
|
2023
Q1 | $14K | Buy |
+894
| New | +$14K | ﹤0.01% | 5785 |
|